Modified Subxiphoid Thoracoscopic Thymectomy for Locally Invasive Thymoma

Jiang, Jiahao; Gao, Jian; Zhang, Yi; Wang, Hao; Tan, Liang; Ding, Jianyong

doi:10.1016/j.athoracsur.2020.10.032

Cited by 19 publications

(16 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The thoracoscopic subxiphoid approach does not need to split the sternum or enter the chest on both sides. After lifting the anterior chest wall with carbon dioxide (CO 2 ) artificial pneumothorax and sternal retractor, the subxiphoid approach has a very good field of vision and sufficient operating space, so it is effective for patients with myasthenia gravis who need anterior mediastinal tumor resection or thymectomy [ 31 ].…”

Section: Discussionmentioning

confidence: 99%

Clinical Application of Thoracoscopic Resection of Anterior Mediastinal Tumors under the Xiphoid Process

Zhu

Jin

et al. 2022

BioMed Research International

View full text Add to dashboard Cite

Objective. To explore the feasibility and advantages of thoracoscopic resection of anterior mediastinal tumors through subxiphoid and lateral thoracic approaches. Method. 74 patients with anterior mediastinal tumors hospitalized in our hospital from January 2019 to January 2022 were retrospectively analyzed. They were divided into the lateral chest group (31 cases) and the infraxiphoid group (43 cases) according to different operation methods. The tumor size, operation time, intraoperative bleeding, postoperative pain score, postoperative complications, postoperative drainage tube removal time, and hospital stay were compared between the two groups. Result. The intraoperative bleeding and postoperative pain scores in the subxiphoid group were better than those in the lateral chest group. There was no significant difference in operation time and postoperative complications between the two groups. Conclusion. Compared with the lateral thoracic approach, the thoracoscopic subxiphoid approach can be more safe and effective in resectioning anterior mediastinal tumors.

show abstract

Section: Discussionmentioning

confidence: 99%

Clinical Application of Thoracoscopic Resection of Anterior Mediastinal Tumors under the Xiphoid Process

Zhu

Jin

et al. 2022

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…Therefore, the treatment and prognosis of invasive thymoma have become a hot topic in thymoma research. Recent studies of invasive thymoma have focused on more minimally invasive surgical modalities [14] and treatment for neoplasm with intravascular growth [15][16][17].…”

Section: Discussionmentioning

confidence: 99%

The 100 most cited papers on thymoma: a bibliometric analysis

Liu

Zhang

Wang

et al. 2022

Preprint

View full text Add to dashboard Cite

Objectives:This study aims to identify the 100 most cited research articles on thymoma. Methods: The 100 most cited articles on thymoma were identified by searching the Web of Science database. The following important information of selected articles was extracted: author, journal, impact factor, type of article, year of publication, country, organization, and keyword. Results: To our knowledge, this is the first bibliometric study on thymoma. The publication year of the top 100 most cited articles ranged from 1981 to 2018, and the number of citations ranged from 97 to 1182. Most of the included articles are original (75/100) and are mainly retrospective studies (52/75). The United States has the most published articles and citations, and the Annals of Thoracic Surgery is the most sourced journal (n=16). Through VOSviewer analysis, high-density keywords mainly come from thymic carcinoma/invasive thymoma management, immune-related diseases, and laboratory research. Conclusions: Our study summarizes the top 100 most cited articles in the field of thymoma and conducts further analysis. The previous research in this field and possible future research directions are presented.

show abstract

“…In the current clinical guidelines and recommendations, Masaoka stage III thymoma is a contraindication for minimally invasive surgery. 4 To meet the safety and radical surgical requirements, open surgery is recommended, and the application of subxiphoid extended thymectomy with double elevation of the sternum in such patients is controversial.…”

Section: Discussionmentioning

confidence: 99%